Status:

COMPLETED

Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?

Lead Sponsor:

St. Joseph's Healthcare Hamilton

Collaborating Sponsors:

McMaster University

University of Western Ontario, Canada

Conditions:

Coagulation

Bleeding

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Warfarin is highly effective for the prevention of both first and recurrent thrombotic events, however even minor excursions outside the reference INR range of 2.0 to 3.0 are associated with bleeding ...

Detailed Description

What is/are the principal research objective(s) and question(s) to be addressed? Research Objectives: Our broad objective is to improve the quality of anticoagulant care for patients receiving warfari...

Eligibility Criteria

Inclusion

  • Warfarin therapy administered to a target INR of 2.0 to 3.0

Exclusion

  • Out of range INR on day of screening - enrolment will only occur if the patient's INR on the day of screening is between 1.8 and 3.4 (inclusive) - if the INR is outside this range the patient will be re-screened when the INR is within this range.
  • Recent warfarin initiation - all patients must have received warfarin for a minimum of 3 months
  • Planned termination or extended temporary interruption of warfarin within 6 months or anticipated survival of less than 6 months
  • Known severe liver disease, known excess alcohol consumption , known malabsorption syndrome or inability to take oral medications
  • Use of medications known to interfere with warfarin and whose dose is likely to change over the course of the study (e.g. barbiturates, rifampin etc.)
  • Known allergy to vitamin K
  • Inability or unwillingness to follow study procedures or provide consent
  • Prior participation in this study, or participating in a competing study which may impact INR control

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2014

Estimated Enrollment :

235 Patients enrolled

Trial Details

Trial ID

NCT00990158

Start Date

July 1 2010

End Date

April 1 2014

Last Update

May 21 2015

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

Hamilton Health Sciences Centre

Hamilton, Ontario, Canada, L8L 2X2

2

St. Joseph's Hospital

Hamilton, Ontario, Canada, L8N 4A6

3

London Health Sciences Centre

London, Ontario, Canada, N6A 4G5

4

University Health Network, Toronto General Hospital

Toronto, Ontario, Canada, M5G 2C4